GR148672X
CAS No. 263890-70-6
GR148672X ( —— )
Catalog No. M22441 CAS No. 263890-70-6
GR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 87 | In Stock |
|
10MG | 147 | In Stock |
|
25MG | 260 | In Stock |
|
50MG | 372 | In Stock |
|
100MG | 597 | In Stock |
|
200MG | 835 | In Stock |
|
500MG | 1233 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGR148672X
-
NoteResearch use only, not for human use.
-
Brief DescriptionGR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).
-
DescriptionGR148672X is an inhibitor of triacyglycerol hydrolase (TGH) (IC50: 4 nM).
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorTGH
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number263890-70-6
-
Formula Weight340.32
-
Molecular FormulaC15H11F3N2O2S
-
Purity>98% (HPLC)
-
SolubilityDMSO:310 mg/mL (910.91 mM; Need ultrasonic and warming)
-
SMILESCc1cccc(NN=C(C(=O)c2cccs2)C(=O)C(F)(F)F)c1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Catherine Sylvia Borg-Capra, et al. Method of screening for triacyglycerol hydrolase inhibitors . WO 2001016358 A2.
molnova catalog
related products
-
Pomalidomide-PEG2-OH
Pomalidomide-PEG2-OH enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology.
-
Ciprofloxacin EP IMp...
Used as a new type of quinoline anti-bacterial drug ciprofloxacin intermediate.
-
4'-(2-Methylpropyl)a...
Used as pharmaceutical intermediates.